Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis

Huntsville

Paradise Valley

Washington D.C.

Aventura

Clearwater

Ocala

Orlando

Tampa

Coeur d'Alene

Springfield

Wichita

Wheaton

Fall River

St Louis

Lincoln

Charlotte

Cleveland

Dayton

Erie

West Reading

Charleston

Memphis

Austin

Dallas

Duncanville

Lubbock

San Antonio

San Diego

Everett

Graz

Klagenfurt

Vienna

Antwerp

Diepenbeek

Liège

Merksem

České Budějovice

Liberec

Ostrava Trebovice

Prague

Praha4 -KRC

Uherské Hradiště

Berlin

Cologne

Gortlitz

Hamburg

Jena

Leipzig

Ratingen

Dublin

Waterford

Birmingham

Cannock

Colchester

Glasgow

Harrogate

London

Manchester

Metropolitan Borough of Wirral

Oxford

Peterborough